The Global Neurovascular Devices Market Size is projected to grow at a CAGR of 8.40% during the forecast period from 2026 to 2034 | DelveInsight

DelveInsight's Neurovascular Devices Market Insights Report 2034 provides the current and forecast market analysis, individual leading Neurovascular Devices companies' market shares, challenges, Neurovascular Devices Market Drivers, barriers, trends, and key market Neurovascular Devices companies in the market.

To read more about the latest highlights related to the Neurovascular Devices Market @ https://www.delveinsight.com/sample-request/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Neurovascular Devices Market Report

* In May 2025, Terumo Interventional Systems announced the commercial launch of its FDA-approved ROADSAVER Carotid Stent System, designed for use with the Nanoparasol Embolic Protection System to treat carotid artery stenosis in patients at elevated risk from carotid endarterectomy. Strategic significance: Expands treatment options for a higher-risk carotid stenosis patient population.
* In April 2025, Terumo Neuro's Dual-Layer Micromesh Carotid Stent System received FDA Premarket Approval, the first of its kind in the US, targeting carotid stenosis including de novo and post-endarterectomy restenotic lesions. Strategic significance: Offers a significant new option for patients at higher risk following endarterectomy.
* In June 2024, Penumbra announced the CE Mark and European launch of BMX 81 and BMX 96, designed for the neurovascular management of both ischemic and hemorrhagic strokes and representing the company's most advanced neuro access technologies to date. Strategic significance: Reflects continued emphasis on innovation and clinical efficacy in stroke intervention technology.
* The Neurovascular Devices market is expected to increase from USD 3,904.74 million in 2025 to USD 8,044.66 million by 2034, reflecting strong and sustained growth.
* The global Neurovascular Devices market is growing at a CAGR of 8.40% during the forecast period from 2026 to 2034.
* The principal drivers are the increasing prevalence of neurological disorders such as stroke, cerebral aneurysms, and arteriovenous malformations; increasing technological advancements in devices such as stent retrievers, flow diverters, and AI-enabled imaging systems; and rising product development activity among key market players.
* The leading Neurovascular Devices Companies include Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, and Perflow Medical Ltd., among others.

To know more about why North America is leading the market growth in the Neurovascular Devices Market, Get a snapshot @ https://www.delveinsight.com/sample-request/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Neurovascular Devices Overview

Neurovascular devices are specialized medical devices used to diagnose and treat disorders affecting the blood vessels of the brain and spinal cord, primarily used in minimally invasive procedures to manage stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular diseases. Common examples include stent retrievers, flow diverters, embolization coils, thrombectomy devices, and microcatheters, which help restore blood flow, prevent vessel rupture, or block abnormal blood vessels in the brain. The market spans cerebral embolization and aneurysm coiling devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices, used across stroke, cerebral aneurysm, and carotid artery stenosis applications.

Neurovascular Devices Market Key Growth Drivers

* The increasing prevalence of neurological disorders such as stroke, brain aneurysms, and arteriovenous malformations is a key driver, with DelveInsight estimating the 7MM accounted for over 1.5 million cases of acute ischemic stroke, alongside more than 3.5 million new intracerebral hemorrhagic stroke cases and roughly 1.3 million new subarachnoid hemorrhagic stroke cases globally each year.
* Increasing technological advancements in devices, including next-generation stent retrievers, flow diverters, embolic coils, and AI-enabled imaging systems, are enhancing precision, safety, and success rates of minimally invasive procedures.
* An increase in product development activities among key market players is introducing more advanced, safer, and minimally invasive treatment options, improving procedural success rates for conditions such as stroke and cerebral aneurysms.

Get a sneak peek at the Neurovascular Devices Market Dynamics @ https://www.delveinsight.com/sample-request/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Neurovascular Devices Market Segment Analysis

The Neurovascular Devices Market by Product Type (Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]), Application (Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography.

By product type, within cerebral balloon angioplasty and stenting systems, carotid artery stents are projected to dominate in 2025 with roughly 65% share of that category, offering less invasive, highly effective treatment for carotid artery disease, a leading cause of ischemic stroke. By application, stroke is projected to account for the largest share at 55% in 2025, driven by the high prevalence of ischemic strokes and the standardization of minimally invasive thrombectomy as the standard of care for eligible patients. By end-user, hospitals dominate the market given their investment in advanced imaging systems, catheterization labs, and specialized stroke care units. North America is expected to account for the highest proportion, 38% of the market, in 2025, while Asia-Pacific is emerging as a major growth driver.

Which MedTech key players in the Neurovascular Devices Market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/sample-request/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Neurovascular Devices Market Competitive Landscape

The competitive landscape of the Neurovascular Devices market is moderately consolidated, with a handful of global leaders holding substantial market share while regional players and emerging startups are steadily gaining traction. Major companies such as Medtronic, Stryker, Johnson & Johnson, Penumbra, and Terumo dominate with comprehensive portfolios of neurovascular stents, coils, thrombectomy devices, and embolization systems, strengthening their positions through continuous innovation, integration of imaging and navigation technologies, and strategic acquisitions such as Stryker's acquisition of Inari Medical.

Neurovascular Devices Companies

Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.

Neurovascular Devices Market Restraints

The growing number of product recalls, particularly those related to safety concerns, device malfunctions, or quality control issues, is expected to negatively impact future growth of the Neurovascular Devices market. Recalls result in financial losses for manufacturers and damage brand reputation, reducing physician and patient confidence in advanced neurovascular technologies. Stringent regulatory approval processes imposed by authorities such as the FDA and EMA further act as a limiting factor, as these high-risk, life-saving devices must undergo extensive clinical trials and rigorous safety evaluations before approval, increasing development timelines and costs.

Interested in knowing the Neurovascular Devices Market by 2034? Click to get a snapshot of the Neurovascular Devices Market Trends-https://www.delveinsight.com/sample-request/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Neurovascular Devices Market Report

* Coverage- Global
* Forecast Period- 2026-2034
* Neurovascular Devices Companies- Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., and others.
* Neurovascular Devices Market Restraints and Regulatory Analysis
* Neurovascular Devices Porter Five Forces Analysis and Market Assessment

Explore more information of the Neurovascular Devices Market Insights @ https://www.delveinsight.com/sample-request/neurovascular-devices-interventional-neurology-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

1. Neurovascular Devices Market Report Introduction
2. Neurovascular Devices Market Executive Summary
3. Neurovascular Devices Market Key Factors Analysis
4. Impact Analysis
5. Regulatory Analysis
6. Neurovascular Devices Market Porter's Five Forces Analysis
7. Neurovascular Devices Market Assessment
8. Competitive Landscape
9. Startup Funding & Investment Trends
10. Neurovascular Devices Market Company and Product Profiles
11. Neurovascular Devices KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer & Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.